Results From 2 Proof-of-Concept, Placebo-Controlled Studies of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder - Concepedia

Concepedia

Publication | Closed Access

Results From 2 Proof-of-Concept, Placebo-Controlled Studies of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder

336

Citations

0

References

2002

Year

Thomas Spencer, John H. Heiligenstein, Joseph Biederman, Douglas E. Faries, Christopher J. Kratochvil, C. Keith Conners, William Z. Potter

The Journal of Clinical Psychiatry

Abstract

Two studies of atomoxetine early in its development confirmed that atomoxetine, a specific and selective inhibitor of noradrenergic uptake, was effective for the treatment of children with ADHD. In addition, atomoxetine was found to be well tolerated.